Investigation of factors affecting patients' preference of biologics treatment modes with rheumatoid arthritis
Not Applicable
- Conditions
- rheumatoid arthritis
- Registration Number
- JPRN-UMIN000042203
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
No specific criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Factors affecting the preference of treatment modes of rheumatoid arthritis patients using biologic disease-modifying antirheumatic drugs.
- Secondary Outcome Measures
Name Time Method *Presence or absence of a gap from the current treatment modes. *Factors which desire to change the treatment modes in the future.